Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head.

Hepato-gastroenterology - 1 Jan 2000

Gazzaniga G M, Papadia F S, Dezzana M, Cappato S, Filauro M, Bandelloni R

Abstract excerpt

BACKGROUND/AIMS: To determine the role of p53 mutations on survival after pancreatoduodenectomy for adenocarcinoma of the pancreatic head. METHODOLOGY: Resected specimens were assessed for expression of wild-type or mutated p53. Survival of p53-negative and- positive patients was investigated, an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Ductal, Breast
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Staging

Share to Pancreatectomy

Share to Pancreatic Neoplasms

Share to Survival Analysis

Source

Identifiers

PMID: 11813614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11813614-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head.PMID 11813614Read ↗

High p53 Protein Level Is a Negative Prognostic Marker for Pancreatic Adenocarcinoma.Semantic proximity Read ↗

p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.Semantic proximity Read ↗

Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.Semantic proximity Read ↗

Association of p53 gene mutations with short survival in pancreatic adenocarcinoma.Semantic proximity Read ↗

The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.Semantic proximity Read ↗

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.Semantic proximity Read ↗

Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival.Semantic proximity Read ↗

Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.Semantic proximity Read ↗

p53 correlates with improved survival in patients with esophageal adenocarcinoma.Semantic proximity Read ↗

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Prognostic significance of the p53 mutation in esophageal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.